InsiderClue
← All stocks

Aurinia Pharmaceuticals Inc.

AUPH Net buying
CIK 0001600620 #1941 in the set updated 17 Sep 2026
Bought (120 mo)
$63.16M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$42.41M
$0.00 on a plan · $21.68M straight out of an exercise
Sold at will
$20.73M
61 of 80 sales
Net
+$20.75M
+$42.43M against sales at will

By person

25 insiders · 130 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
TANG KEVIN
Chief Executive Officer
$62.27M (23)
—
+$62.27M
13,044,106
9.80%
$208.05M
+80.4%
Solomons Neil
Chief Medical Officer
—
$13.31M (10) scheduled
−$13.31M
90,953
0.0684%
$1.45M
−51.4%
Martin Michael Robert
Chief Business Officer
$154.80K (1)
$12.85M (19) scheduled
−$12.70M
259,162
0.1948%
$4.13M
−1.9%
Huizinga Robert Bindert
EVP of Research
—
$5.48M (8) scheduled
−$5.48M
69,379
0.0521%
$1.11M
−33.0%
Greenleaf Peter
Chief Executive Officer
$54.89K (2)
$3.98M (5)
−$3.93M
1,840,379
1.38%
$29.35M
+448.8%
Robertson Stephen P.
Chief Legal Officer
$14.53K (1)
$2.02M (6)
−$2.00M
588,848
0.4426%
$9.39M
+413.0%
Miller Joseph M
Chief Financial Officer
$9.74K (1)
$1.27M (5)
−$1.26M
576,421
0.4332%
$9.19M
+396.1%
Donley Matthew Maxwell
Chief Operating Officer
$146.34K (2)
$1.26M (4)
−$1.11M
680,299
0.5113%
$10.85M
+474.2%
Hagan Joseph P
Director
—
$906.53K (3) scheduled
−$906.53K
11,961
0.0090%
$190.78K
+241.7%
Keenan Greg
SVP, Chief Medical Officer
—
$376.26K (3)
−$376.26K
154,449
0.1161%
$2.46M
+38.6%
MILNE GEORGE M JR
Director
$297.38K (3)
—
+$297.38K
78,733
0.0592%
$1.26M
+96.8%
Habig Scott Michael
Chief Commercial Officer
$25.08K (1)
$283.40K (3)
−$258.33K
456,338
0.3430%
$7.28M
+231.8%
Knappertz Volker
EVP, Research and Development
—
$167.87K (2)
−$167.87K
319,128
0.2399%
$5.09M
+102.3%
Jayne David R.W.
Director
—
$126.72K (2)
−$126.72K
56,499
0.0425%
$901.16K
+41.2%
Billen Daniel
Director
—
$82.51K (2)
−$82.51K
28,141
0.0212%
$448.85K
+40.7%
Smith Karen L.
Director
—
$44.18K (1)
−$44.18K
24,807
0.0186%
$395.67K
—
Colao Massimilano
Chief Commercial Officer
—
$38.49K (1)
−$38.49K
13,495
0.0101%
$215.25K
+64.6%
Bailey Jeffrey Allen
Director
—
$38.42K (1)
−$38.42K
22,775
0.0171%
$363.26K
—
MacKay-Dunn R. Hector
Former Director
$105.51K (5)
$86.57K (2)
+$18.95K
18,595
0.0140%
$296.59K
+1,140%
Balakrishnan Brinda
Director
—
$2.98K (1)
−$2.98K
17,523
0.0132%
$279.49K
—
Leversage Jill
Director
$85.10K (4)
$86.42K (2)
−$1.32K
26,453
0.0199%
$421.93K
+2,545%
Hearne Michael S
Chief Financial Officer
—
—
—
116,144
0.0873%
$1.85M
—
Cole Ryan
Chief Operating Officer
—
—
—
116,144
0.0873%
$1.85M
—
Hayden Michael R
Director
—
—
—
95,000
0.0714%
$1.52M
—
Johnson Craig A
Director
—
—
—
14,592
0.0110%
$232.74K
—

Individual transactions

130
Insider
Date
Role
Action
Shares
Price
Amount
Robertson Stephen P.
10 Sep 2026
Chief Legal Officer
Sell
11,939
$15.95
$190.43K
Robertson Stephen P.
21 Aug 2026
Chief Legal Officer
Sell
20,975
$16.97
$355.95K
TANG KEVIN
2 Jun 2026
Chief Executive Officer
Buy indirect
206,005
$15.28
$3.15M
TANG KEVIN
1 Jun 2026
Chief Executive Officer
Buy indirect
99
$15.34
$1.52K
TANG KEVIN
1 Jun 2026
Chief Executive Officer
Buy indirect
343,521
$15.28
$5.25M
TANG KEVIN
29 May 2026
Chief Executive Officer
Buy indirect
262,682
$15.31
$4.02M
TANG KEVIN
29 May 2026
Chief Executive Officer
Buy indirect
2,299
$15.35
$35.29K
TANG KEVIN
3 Mar 2026
Director
Buy indirect
184,208
$14.22
$2.62M
TANG KEVIN
2 Mar 2026
Director
Buy indirect
115,792
$14.21
$1.65M
TANG KEVIN
2 Mar 2026
Director
Buy indirect
83,561
$14.33
$1.20M
TANG KEVIN
27 Feb 2026
Director
Buy indirect
1,600
$14.38
$23.01K
TANG KEVIN
27 Feb 2026
Director
Buy indirect
214,839
$14.12
$3.03M
TANG KEVIN
27 Feb 2026
Director
Buy indirect
300,000
$13.90
$4.17M
TANG KEVIN
5 Aug 2025
Director
Buy indirect
200,000
$11.68
$2.34M
TANG KEVIN
4 Aug 2025
Director
Buy indirect
100,000
$11.34
$1.13M
Keenan Greg
1 Aug 2025
Chief Medical Officer
Sell
20,000
$10.50
$210.00K
TANG KEVIN
1 Aug 2025
Director
Buy indirect
1,000,000
$10.12
$10.12M
Keenan Greg
7 Mar 2025
Chief Medical Officer
Sell
8,305
$8.23
$68.35K
TANG KEVIN
4 Mar 2025
Director
Buy indirect
100,000
$8.09
$809.00K
TANG KEVIN
4 Mar 2025
Director
Buy indirect
500,000
$7.92
$3.96M
TANG KEVIN
4 Mar 2025
Director
Buy indirect
148,038
$8.00
$1.18M
Donley Matthew Maxwell
4 Mar 2025
Chief Operating Officer
Sell
58,991
$7.92
$467.21K
Robertson Stephen P.
4 Mar 2025
EVP, General Counsel
Sell
57,607
$7.92
$456.25K
Miller Joseph M
4 Mar 2025
Chief Financial Officer
Sell
56,154
$7.92
$444.74K
Greenleaf Peter
4 Mar 2025
Chief Executive Officer
Sell
164,947
$7.92
$1.31M
TANG KEVIN
3 Mar 2025
Director
Buy indirect
351,962
$8.02
$2.82M
TANG KEVIN
3 Mar 2025
Director
Buy indirect
100,720
$7.97
$802.74K
Donley Matthew Maxwell
3 Mar 2025
Chief Operating Officer
Sell
65,902
$8.00
$527.22K
Robertson Stephen P.
3 Mar 2025
EVP, General Counsel
Sell
64,872
$8.00
$518.98K
Miller Joseph M
3 Mar 2025
Chief Financial Officer
Sell
61,859
$8.00
$494.87K
Keenan Greg
3 Mar 2025
Chief Medical Officer
Sell
12,239
$8.00
$97.91K
Greenleaf Peter
3 Mar 2025
Chief Executive Officer
Sell
195,593
$8.00
$1.56M
TANG KEVIN
28 Feb 2025
Director
Buy indirect
399,280
$7.85
$3.13M
TANG KEVIN
9 Dec 2024
Director
Buy indirect
500,000
$9.09
$4.55M
TANG KEVIN
6 Dec 2024
Director
Buy indirect
400,000
$9.01
$3.60M
TANG KEVIN
5 Dec 2024
Director
Buy indirect
300,000
$8.91
$2.67M
Smith Karen L.
11 Nov 2024
Director
Sell
5,241
$8.43
$44.18K
Bailey Jeffrey Allen
11 Nov 2024
Director
Sell
4,557
$8.43
$38.42K
Habig Scott Michael
6 Aug 2024
Chief Commercial Officer
Sell
18,249
$5.31
$96.90K
MacKay-Dunn R. Hector
21 May 2024
Director
Sell
5,630
$5.74
$32.32K
Leversage Jill
21 May 2024
Director
Sell
5,610
$5.74
$32.20K
Jayne David R.W.
21 May 2024
Director
Sell
4,946
$5.74
$28.39K
Billen Daniel
21 May 2024
Director
Sell
5,252
$5.74
$30.15K
Balakrishnan Brinda
21 May 2024
Director
Sell
520
$5.74
$2.98K
Robertson Stephen P.
6 Mar 2024
EVP, General Counsel
Sell
57,745
$5.60
$323.37K
Habig Scott Michael
6 Mar 2024
Chief Commercial Officer
Sell
17,777
$5.60
$99.55K
Donley Matthew Maxwell
6 Mar 2024
EVP, Ops & Strategy
Sell
40,665
$5.51
$224.06K
Miller Joseph M
6 Mar 2024
Chief Financial Officer
Sell
34,811
$5.60
$194.94K
Greenleaf Peter
6 Mar 2024
Chief Executive Officer
Sell
126,981
$5.60
$711.09K
Knappertz Volker
27 Feb 2024
EVP, Research and Development
Sell
4,930
$6.10
$30.07K
Habig Scott Michael
20 Feb 2024
Chief Commercial Officer
Sell
15,867
$5.48
$86.95K
Knappertz Volker
20 Feb 2024
EVP, Research and Development
Sell
25,146
$5.48
$137.80K
Leversage Jill
23 May 2023
Director
Sell
4,815
$11.26
$54.22K
MacKay-Dunn R. Hector
23 May 2023
Director
Sell
4,818
$11.26
$54.25K
Billen Daniel
23 May 2023
Director
Sell
4,650
$11.26
$52.36K
Jayne David R.W.
23 May 2023
Director
Sell
8,733
$11.26
$98.33K
Hagan Joseph P
19 May 2023
Director
Sell
272
$10.58
$2.88K
Greenleaf Peter
2 Mar 2023
Chief Executive Officer
Sell
32,750
$8.94
$292.79K
Robertson Stephen P.
2 Mar 2023
EVP, General Counsel
Sell
19,402
$8.94
$173.45K
Miller Joseph M
2 Mar 2023
Chief Financial Officer
Sell
11,296
$8.94
$100.99K
MILNE GEORGE M JR
2 Mar 2023
Director
Buy
20,000
$8.91
$178.28K
Donley Matthew Maxwell
21 Nov 2022
Ex VP, Internal Operations
Buy
10,000
$4.66
$46.60K
Habig Scott Michael
9 Nov 2022
Chief Commercial Officer
Buy
5,000
$5.02
$25.08K
Martin Michael Robert
7 Nov 2022
Chief Business Officer
Buy
30,000
$5.16
$154.80K
MacKay-Dunn R. Hector
9 Mar 2022
Director
Buy
5,000
$11.00
$54.99K
MILNE GEORGE M JR
4 Mar 2022
Director
Buy
5,000
$10.82
$54.10K
Huizinga Robert Bindert
2 Mar 2022
EVP of Research
Sell
4,849
$12.01
$58.24K
Solomons Neil
2 Mar 2022
Chief Medical Officer
Sell
4,846
$12.01
$58.20K
Greenleaf Peter
2 Mar 2022
Chief Executive Officer
Sell
9,068
$12.01
$108.91K
Colao Massimilano
2 Mar 2022
Chief Commercial Officer
Sell
3,205
$12.01
$38.49K
Miller Joseph M
2 Mar 2022
Chief Financial Officer
Sell
3,060
$12.01
$36.75K
Donley Matthew Maxwell
2 Mar 2022
Ex VP, Intern'l Operations
Sell
3,052
$12.01
$36.65K
Martin Michael Robert
2 Mar 2022
Chief Business Officer
Sell
4,849
$12.01
$58.24K
Hagan Joseph P
3 Jan 2022
Director
Sold after exercise
634
$23.29
$14.77K
Hagan Joseph P
3 Jan 2022
Director
Sold after exercise
39,366
$22.58
$888.88K
Leversage Jill
13 Dec 2021
Director
Buy
1,600
$20.04
$32.06K
Solomons Neil
11 Nov 2021
Chief Medical Officer
Sold after exercise
100,000
$28.89
$2.89M
Martin Michael Robert
11 Nov 2021
Chief Business Officer
Sold after exercise
11,000
$29.50
$324.50K
Martin Michael Robert
11 Nov 2021
Chief Business Officer
Sold after exercise
29,000
$28.82
$835.78K
Solomons Neil
10 Nov 2021
Chief Medical Officer
Sold after exercise
10,000
$30.55
$305.50K
Solomons Neil
10 Nov 2021
Chief Medical Officer
Sold after exercise
90,000
$31.17
$2.81M
Martin Michael Robert
10 Nov 2021
Chief Business Officer
Sell
10,000
$30.55
$305.50K
Martin Michael Robert
10 Nov 2021
Chief Business Officer
Sell
50,000
$31.26
$1.56M
Solomons Neil
9 Nov 2021
Chief Medical Officer
Sell
50,000
$30.17
$1.51M
Martin Michael Robert
9 Nov 2021
Chief Business Officer
Sell
50,000
$30.17
$1.51M
Martin Michael Robert
1 Nov 2021
Chief Business Officer
Sold after exercise
45,000
$31.64
$1.42M
Solomons Neil
1 Nov 2021
Chief Medical Officer
Sold after exercise
45,000
$31.64
$1.42M
Huizinga Robert Bindert
25 Oct 2021
EVP of Research
Sold after exercise
130,000
$29.75
$3.87M
Martin Michael Robert
21 Sep 2021
Chief Business Officer
Sold after exercise
87,500
$24.02
$2.10M
Huizinga Robert Bindert
21 Sep 2021
EVP of Research
Sold after exercise
5,364
$23.66
$126.91K
Huizinga Robert Bindert
21 Sep 2021
EVP of Research
Sold after exercise
27,136
$24.05
$652.62K
Martin Michael Robert
20 Sep 2021
Chief Business Officer
Sold after exercise
16,000
$21.60
$345.60K
Martin Michael Robert
20 Sep 2021
Chief Business Officer
Sold after exercise
12,500
$21.71
$271.38K
Huizinga Robert Bindert
14 Sep 2021
EVP of Research
Sell
22,500
$21.75
$489.38K
Martin Michael Robert
14 Sep 2021
Chief Business Officer
Sold after exercise
90,000
$21.19
$1.91M
Martin Michael Robert
14 Sep 2021
Chief Business Officer
Sold after exercise
30,000
$21.80
$654.00K
Martin Michael Robert
14 Sep 2021
Chief Business Officer
Sold after exercise
14,000
$21.73
$304.22K
Solomons Neil
13 Sep 2021
Chief Medical Officer
Exercised, kept
150,000
$3.20
$480.00K
Martin Michael Robert
13 Sep 2021
Chief Business Officer
Exercised, kept
25,000
$5.30
$132.50K
Solomons Neil
10 Sep 2021
Chief Medical Officer
Sell
150,000
$19.84
$2.98M
Huizinga Robert Bindert
10 Sep 2021
EVP of Research
Sell
5,000
$19.76
$98.80K
Huizinga Robert Bindert
10 Sep 2021
EVP of Research
Sell
5,000
$19.83
$99.15K
Martin Michael Robert
10 Sep 2021
Chief Business Officer
Sell
25,000
$19.80
$495.00K
Huizinga Robert Bindert
7 Sep 2021
EVP of Research
Sell
5,000
$18.30
$91.50K
Martin Michael Robert
7 Sep 2021
Chief Business Officer
Sell
7,500
$18.10
$135.75K
Martin Michael Robert
26 Aug 2021
Chief Business Officer
Sell
22,500
$17.81
$400.73K
Solomons Neil
25 Aug 2021
Chief Medical Officer
Sell
5,000
$15.85
$79.25K
Martin Michael Robert
9 Aug 2021
Chief Business Officer
Sell
5,000
$16.01
$80.05K
Solomons Neil
9 Aug 2021
Chief Medical Officer
Sell
45,000
$16.03
$721.35K
Martin Michael Robert
28 Jul 2021
Chief Business Officer
Sell
5,000
$13.86
$69.30K
Martin Michael Robert
22 Jun 2021
Chief Business Officer
Sell
5,000
$13.76
$68.80K
MacKay-Dunn R. Hector
12 May 2021
Director
Buy
1,600
$11.28
$18.04K
MacKay-Dunn R. Hector
12 May 2021
Director
Buy
1,400
$11.26
$15.76K
Miller Joseph M
11 May 2021
Chief Financial Officer
Buy
1,000
$9.74
$9.74K
Huizinga Robert Bindert
11 May 2021
Ex Vice President of Research
Exercised, kept
40,000
$3.02
$120.80K
Leversage Jill
11 May 2021
Director
Buy
2,500
$10.96
$27.39K
Martin Michael Robert
11 May 2021
Chief Business Officer
Exercised, kept
20,000
$3.02
$60.40K
Greenleaf Peter
11 May 2021
Chief Executive Officer
Buy
2,992
$11.11
$33.24K
Greenleaf Peter
11 May 2021
Chief Executive Officer
Buy
2,133
$10.15
$21.65K
Donley Matthew Maxwell
11 May 2021
Ex VP, Intern'l Operations
Buy
9,900
$10.07
$99.74K
MacKay-Dunn R. Hector
11 May 2021
Director
Buy
1,000
$11.14
$11.14K
MacKay-Dunn R. Hector
11 May 2021
Director
Buy
500
$11.17
$5.59K
Solomons Neil
12 Mar 2021
Chief Medical Officer
Sold after exercise
40,000
$13.49
$539.60K
MILNE GEORGE M JR
5 Mar 2021
Director
Buy
5,000
$13.00
$65.00K
Hayden Michael R
29 Jan 2021
Director
Exercised, kept
15,000
$6.42
$96.30K
Hayden Michael R
29 Jan 2021
Director
Exercised, kept
30,000
$6.06
$181.80K
Hayden Michael R
29 Jan 2021
Director
Exercised, kept
50,000
$5.44
$272.00K
Leversage Jill
29 Jan 2021
Director
Buy
1,200
$16.03
$19.24K
Leversage Jill
29 Jan 2021
Director
Buy indirect
400
$16.03
$6.41K
Robertson Stephen P.
28 Jan 2021
EVP, General Counsel
Buy
900
$16.14
$14.53K

What was left out

Form 4 filings counted 150
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 19
Sales at will 61
Transactions with no price 0
Shares from compensation/vesting 7,752,523
Sales filed before the plan box existed 27
History held since 29 Jan 2021